- Home
- CATX vs AXGN Comparison
CATX vs AXGN Comparison
Compare CATX & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- AXGN
- Stock Information
- Founded
- CATX 1983
- AXGN N/A
- Country
- CATX United States
- AXGN United States
- Employees
- CATX N/A
- AXGN 428
- Industry
- CATX Medical/Dental Instruments
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CATX Health Care
- AXGN Health Care
- Exchange
- CATX Nasdaq
- AXGN Nasdaq
- Market Cap
- CATX 782.7M
- AXGN 648.7M
- IPO Year
- CATX N/A
- AXGN N/A
- Fundamental
- Price
- CATX $3.07
- AXGN $14.74
- Analyst Decision
- CATX Strong Buy
- AXGN Strong Buy
- Analyst Count
- CATX 9
- AXGN 4
- Target Price
- CATX $17.25
- AXGN $15.00
- AVG Volume (30 Days)
- CATX 2.7M
- AXGN 201.0K
- Earning Date
- CATX 11-12-2024
- AXGN 11-07-2024
- Dividend Yield
- CATX N/A
- AXGN N/A
- EPS Growth
- CATX N/A
- AXGN N/A
- EPS
- CATX N/A
- AXGN N/A
- Revenue
- CATX $1,557,000.00
- AXGN $180,855,000.00
- Revenue This Year
- CATX N/A
- AXGN $18.91
- Revenue Next Year
- CATX N/A
- AXGN $13.02
- P/E Ratio
- CATX N/A
- AXGN N/A
- Revenue Growth
- CATX N/A
- AXGN 18.79
- 52 Week Low
- CATX $2.50
- AXGN $5.55
- 52 Week High
- CATX $19.10
- AXGN $15.90
- Technical
- Relative Strength Index (RSI)
- CATX 20.31
- AXGN 57.65
- Support Level
- CATX $3.27
- AXGN $13.85
- Resistance Level
- CATX $3.60
- AXGN $15.25
- Average True Range (ATR)
- CATX 0.33
- AXGN 0.53
- MACD
- CATX 0.21
- AXGN 0.02
- Stochastic Oscillator
- CATX 0.00
- AXGN 68.52
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.